Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 4 Grant or award Chief People Officer acquired 19,520 shares (grant or award)
  2. 4 Grant or award Chief Operating Officer acquired 43,295 shares (grant or award)
  3. 4 Grant or award President, Mental Health acquired 22,616 shares (grant or award)
  4. 4 Grant or award President and CEO acquired 234,271 shares (grant or award)
  5. 5 Insider Annual Insider Trading Report
  6. 4 Insider Changes in Ownership
  7. 4 Grant or award Lambert Nicole acquired 10,000 shares (grant or award)
  8. 4 Grant or award Chief People Officer acquired 143 shares (grant or award)
  9. 3/A Insider 3/A
  10. 4 Grant or award Chief Legal Officer acquired 15,753 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Shares withheld for taxes President, Myriad Neuroscience gave up 8,340 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Financial Officer gave up 12,398 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Scientific Officer gave up 10,811 shares (to pay taxes)
  15. 4 Shares withheld for taxes Lambert Nicole gave up 12,483 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief People Officer gave up 4,926 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Technology Officer gave up 1,729 shares (to pay taxes)
  18. 3/A Insider 3/A
  19. 4 Open-market sale Lambert Nicole sold 1,420 shares at $31.57 ($44,835)
  20. 4 Open-market sale Lambert Nicole sold 10,112 shares at $33.10 ($334,747)

Page 16 of 65 · 1,294 filings